Beactica and Johnson & Johnson's Janssen Pharmaceutica N.V. unit. will use Beatica Sprint technology to discover small molecules against undisclosed targets

Beactica AB

Sweden / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced